{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:44:08Z","timestamp":1792014248543,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hanmi Pharmaceutical, Seoul, South Korea"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s40263-026-01321-9","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:18:42Z","timestamp":1785741522000},"page":"1513-1526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and Safety of an Early Aggressive Lipid-Lowering Strategy Using Triple Therapy After Mechanical Thrombectomy"],"prefix":"10.1007","volume":"40","author":[{"given":"Ho Geol","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Yeon","family":"Eun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejung","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0765-9891","authenticated-orcid":false,"given":"Hee-Kwon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"1321_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102758","author":"X-y Li","year":"1990","unstructured":"Li X-y, Kong X-m, Yang C-h, Cheng Z-f, Lv J-j, Guo H, et al. Global, regional, and national burden of ischemic stroke, 1990\u20132021: an analysis of data from the global burden of disease study 2021. eClinicalMedicine. 1990. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102758.","journal-title":"eClinicalMedicine"},{"issue":"12","key":"1321_CR2","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"},{"issue":"1","key":"1321_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/1747493015609778","volume":"11","author":"N Wahlgren","year":"2016","unstructured":"Wahlgren N, Moreira T, Michel P, Steiner T, Jansen O, Cognard C, et al. Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014\/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke. 2016;11(1):134\u201347.","journal-title":"Int J Stroke"},{"issue":"4","key":"1321_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1177\/15910199221135289","volume":"30","author":"H Kobeissi","year":"2024","unstructured":"Kobeissi H, Ghozy S, Seymour T, Bilgin C, Kadirvel R, Kallmes DF. Early neurological deterioration as a predictor of outcomes after endovascular thrombectomy for stroke: a systematic review and meta-analysis. Interv Neuroradiol. 2024;30(4):451\u20137.","journal-title":"Interv Neuroradiol"},{"issue":"3","key":"1321_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00415-018-09173-0","volume":"266","author":"JM Kim","year":"2019","unstructured":"Kim JM, Bae JH, Park KY, Lee WJ, Byun JS, Ahn SW, et al. Incidence and mechanism of early neurological deterioration after endovascular thrombectomy. J Neurol. 2019;266(3):609\u201315.","journal-title":"J Neurol"},{"issue":"12","key":"1321_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1212\/WNL.0000000000200030","volume":"98","author":"TN Turan","year":"2022","unstructured":"Turan TN, Zaidat OO, Gronseth GS, Chimowitz MI, Culebras A, Furlan AJ, et al. Stroke prevention in symptomatic large artery intracranial atherosclerosis practice advisory: report of the AAN Guideline Subcommittee. Neurology. 2022;98(12):486\u201398.","journal-title":"Neurology"},{"issue":"7","key":"1321_CR7","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2021;52(7):e364\u2013467.","journal-title":"Stroke"},{"issue":"8","key":"1321_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/eurheartj\/ehab718","volume":"43","author":"KK Ray","year":"2022","unstructured":"Ray KK, Reeskamp LF, Laufs U, Banach M, Mach F, Tokg\u00f6zo\u011flu LS, et al. Combination lipid-lowering therapy as first-line strategy in very high-risk patients. Eur Heart J. 2022;43(8):830\u20133.","journal-title":"Eur Heart J"},{"issue":"6 Suppl 2","key":"1321_CR9","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1016\/j.amepre.2006.08.019","volume":"31","author":"BC Lee","year":"2006","unstructured":"Lee BC, Roh JK. International experience in stroke registries: Korean Stroke Registry. Am J Prev Med. 2006;31(6 Suppl 2):S243\u20135.","journal-title":"Am J Prev Med"},{"key":"1321_CR10","doi-asserted-by":"crossref","unstructured":"Kim M, Lee S-J, Park SY, Hong JM, Lee JS. A novel etiological classification in patients with intracranial large vessel occlusion and endovascular treatment: discordance with the classic and SSS TOAST systems: a retrospective cohort study. Precis Future Med. 2023 6;7(2):83-9.","DOI":"10.23838\/pfm.2023.00065"},{"issue":"7","key":"1321_CR11","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s40262-017-0620-7","volume":"57","author":"S Kasichayanula","year":"2018","unstructured":"Kasichayanula S, Grover A, Emery MG, Gibbs MA, Somaratne R, Wasserman SM, et al. Clinical pharmacokinetics and pharmacodynamics of evolocumab, a PCSK9 inhibitor. Clin Pharmacokinet. 2018;57(7):769\u201379.","journal-title":"Clin Pharmacokinet"},{"issue":"25_suppl_2","key":"1321_CR12","first-page":"S1","volume":"129","author":"NJ Stone","year":"2013","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2013;129(25_suppl_2):S1\u201345.","journal-title":"Circulation"},{"key":"1321_CR13","doi-asserted-by":"crossref","unstructured":"McKenney JM, Davidson MH, Jacobson TA, Guyton JR. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006;97(8, Supplement 1):S89-S94.","DOI":"10.1016\/j.amjcard.2006.02.030"},{"issue":"2","key":"1321_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/a-1762-0167","volume":"84","author":"H Liu","year":"2023","unstructured":"Liu H, Zhang Y, Fan H, Wen C. Risk factors and functional outcomes with early neurological deterioration after mechanical thrombectomy for acute large vessel occlusion stroke. J Neurol Surg B Skull Base. 2023;84(2):183\u201391.","journal-title":"J Neurol Surg B Skull Base"},{"issue":"2","key":"1321_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.010","volume":"25","author":"JM Kim","year":"2016","unstructured":"Kim JM, Moon J, Ahn SW, Shin HW, Jung KH, Park KY. The etiologies of early neurological deterioration after thrombolysis and risk factors of ischemia progression. J Stroke Cerebrovasc Dis. 2016;25(2):383\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"1321_CR16","doi-asserted-by":"crossref","unstructured":"Wang J, Zhao M, Qiao Y, Li S, Ji X, Zhao W. Neurological deterioration after acute ischemic stroke: a common phenomenon with important implications. Cerebrovascu Dis; 2025.","DOI":"10.1159\/000543763"},{"issue":"6","key":"1321_CR17","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1161\/STROKEAHA.108.532465","volume":"40","author":"JA Alawneh","year":"2009","unstructured":"Alawneh JA, Moustafa RR, Baron J-C. Hemodynamic factors and perfusion abnormalities in early neurological deterioration. Stroke. 2009;40(6):e443\u201350.","journal-title":"Stroke"},{"issue":"9","key":"1321_CR18","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/STROKEAHA.109.569459","volume":"41","author":"M Awadh","year":"2010","unstructured":"Awadh M, MacDougall N, Santosh C, Teasdale E, Baird T, Muir KW. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke. Stroke. 2010;41(9):1990\u20135.","journal-title":"Stroke"},{"issue":"7","key":"1321_CR19","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1161\/STROKEAHA.114.005426","volume":"45","author":"P Seners","year":"2014","unstructured":"Seners P, Turc G, Tisserand M, Legrand L, Labeyrie MA, Calvet D, et al. Unexplained early neurological deterioration after intravenous thrombolysis: incidence, predictors, and associated factors. Stroke. 2014;45(7):2004\u20139.","journal-title":"Stroke"},{"issue":"5","key":"1321_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/17474930231156753","volume":"18","author":"GE Mead","year":"2023","unstructured":"Mead GE, Sposato LA, Sampaio Silva G, Yperzeele L, Wu S, Kutlubaev M, et al. A systematic review and synthesis of global stroke guidelines on behalf of the World Stroke Organization. Int J Stroke. 2023;18(5):499\u2013531.","journal-title":"Int J Stroke"},{"key":"1321_CR21","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves OR, de Almeida Monteiro G, Santos AB, Hong A, Pereira MAOM, Fukunaga CK, et al. Impact of pretreatment and early treatment with statins on safety and efficacy outcomes in patients after acute ischemic stroke undergoing endovascular thrombectomy: a systematic review and meta-analysis. Neuroradiology. 2025;67(4):995-1007.","DOI":"10.1007\/s00234-025-03583-4"},{"issue":"9","key":"1321_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1136\/jnis-2023-020619","volume":"16","author":"C Gong","year":"2024","unstructured":"Gong C, Liu C, Wang Y, Chen L, Yuan J, Zhang J, et al. Effect of statin treatment on clinical outcomes in cardioembolic stroke with endovascular thrombectomy. J Neurointerv Surg. 2024;16(9):947\u201354.","journal-title":"J Neurointerv Surg"},{"key":"1321_CR23","doi-asserted-by":"crossref","unstructured":"Gim DH, Choi IY, K, Y-J, Kim HK, Kim SS, Park K-H, Song H, Choi D-H. Short-term effects of PCSK-9 inhibitors on percutaneous coronary intervention in patients with acute coronary syndrome FAU. Korean J Intern Med. 2025;40(3):438-48.","DOI":"10.3904\/kjim.2024.363"},{"issue":"4","key":"1321_CR24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1536\/ihj.22-052","volume":"63","author":"Y Hao","year":"2022","unstructured":"Hao Y, Yang YL, Wang YC, Li J. Effect of the early application of evolocumab on blood lipid profile and cardiovascular prognosis in patients with extremely high-risk acute coronary syndrome. Int Heart J. 2022;63(4):669\u201377.","journal-title":"Int Heart J"},{"key":"1321_CR25","doi-asserted-by":"crossref","unstructured":"Hong K-S, Bang OY, Park J-H, Jung J-M, Lee S-H, Song T-J, et al. Moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin for target low-density lipoprotein cholesterol goal achievement in patients with recent ischemic stroke: a randomized controlled trial. J Stroke 2023;25(2):242-50.","DOI":"10.5853\/jos.2022.02957"},{"issue":"15","key":"1321_CR26","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.jacc.2025.02.007","volume":"85","author":"M Leosdottir","year":"2025","unstructured":"Leosdottir M, Schubert J, Brandts J, Gustafsson S, Cars T, Sundstr\u00f6m J, et al. Early ezetimibe initiation after myocardial infarction protects against later cardiovascular outcomes in the SWEDEHEART registry. J Am Coll Cardiol. 2025;85(15):1550\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"1321_CR27","doi-asserted-by":"crossref","unstructured":"Kim J, Hong U, Yoon CW, Bae JW, Rha J-H, Park H-K. PCSK9 inhibitor in acute ischemic stroke patient receiving mechanical thrombectomy: early outcomes and safety. Front Neurol. 2024;15-2024.","DOI":"10.3389\/fneur.2024.1375609"},{"issue":"10029","key":"1321_CR28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet (Lond Engl). 2016;387(10029):1723\u201331.","journal-title":"Lancet (Lond Engl)."},{"issue":"10321","key":"1321_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(21)01341-6","volume":"399","author":"TG Jovin","year":"2022","unstructured":"Jovin TG, Nogueira RG, Lansberg MG, Demchuk AM, Martins SO, Mocco J, et al. Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis. Lancet. 2022;399(10321):249\u201358.","journal-title":"Lancet"},{"key":"1321_CR30","doi-asserted-by":"crossref","unstructured":"Lee E-J, Jeong H-Y, Kim J, Park NH, Kang MK, Lee D, et al. Procedure time of endovascular thrombectomy as performance measure of acute stroke treatment. NI. 2025;20(2):71-81.","DOI":"10.5469\/neuroint.2025.00178"},{"key":"1321_CR31","doi-asserted-by":"crossref","unstructured":"Sun D, Tong X, Huo X, Jia B, Raynald, Wang A, et al. Unexplained early neurological deterioration after endovascular treatment for acute large vessel occlusion: incidence, predictors, and clinical impact: data from ANGEL-ACT registry. J Neurointervent Surg. 2022;14(9):875-80.","DOI":"10.1136\/neurintsurg-2021-017956"},{"key":"1321_CR32","doi-asserted-by":"crossref","unstructured":"Kim DH, Kim SU, Sung JH, Lee DH, Yi HJ, Lee SW. Significances and outcomes of mechanical thrombectomy for acute infarction in very elderly patients : a single center experience. J Korean Neurosurg Soc. 2017;60(6):654-60.","DOI":"10.3340\/jkns.2016.1212.004"},{"issue":"8","key":"1321_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/jnis-2024-021930","volume":"17","author":"C Heitkamp","year":"2025","unstructured":"Heitkamp C, Winkelmeier L, Flottmann F, Schell M, Kniep H, Broocks G, et al. Thrombectomy patients with minor stroke: factors of early neurological deterioration. J Neurointerv Surg. 2025;17(8):796\u2013802.","journal-title":"J Neurointerv Surg"},{"key":"1321_CR34","doi-asserted-by":"crossref","unstructured":"Guo Y, Zhang S, Li M, Sun B, Shang X, Li S, et al. Leukoaraiosis and earlier neurological outcome after mechanical thrombectomy in acute ischemic stroke. J Neuroradiol. 2020;47(6):428-32.","DOI":"10.1016\/j.neurad.2019.10.005"},{"issue":"1","key":"1321_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5853\/jos.2021.01375","volume":"24","author":"JS Lee","year":"2022","unstructured":"Lee JS, Lee SJ, Hong JM, Alverne F, Lima FO, Nogueira RG. Endovascular treatment of large vessel occlusion strokes due to intracranial atherosclerotic disease. J Stroke. 2022;24(1):3\u201320.","journal-title":"J Stroke"},{"issue":"19","key":"1321_CR36","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","volume":"370","author":"DJ Blom","year":"2014","unstructured":"Blom DJ, Hala T, Bolognese M, Lillestol MJ, Toth PD, Burgess L, et al. A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med. 2014;370(19):1809\u201319.","journal-title":"N Engl J Med"},{"issue":"18","key":"1321_CR37","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.4030","volume":"311","author":"JG Robinson","year":"2014","unstructured":"Robinson JG, Nedergaard BS, Rogers WJ, Fialkow J, Neutel JM, Ramstad D, et al. Effect of evolocumab or ezetimibe added to moderate- or high-intensity statin therapy on LDL-C lowering in patients with hypercholesterolemia: the LAPLACE-2 randomized clinical trial. JAMA. 2014;311(18):1870\u201382.","journal-title":"JAMA"},{"issue":"25","key":"1321_CR38","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387\u201397.","journal-title":"N Engl J Med"},{"issue":"4","key":"1321_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeae055","volume":"4","author":"H Uehara","year":"2024","unstructured":"Uehara H, Kajiya T, Abe M, Nakata M, Hosogi S, Ueda S. Early and short-term use of proprotein convertase anti-subtilisin-kexin type 9 inhibitors on coronary plaque stability in acute coronary syndrome. Eur Heart J Open. 2024;4(4):oeae055.","journal-title":"Eur Heart J Open"},{"key":"1321_CR40","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.atherosclerosis.2023.06.971","volume":"378","author":"R Marfella","year":"2023","unstructured":"Marfella R, Prattichizzo F, Sardu C, Paolisso P, D\u2019Onofrio N, Scisciola L, et al. Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque. Atherosclerosis. 2023;378:117180.","journal-title":"Atherosclerosis"},{"key":"1321_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.amjcard.2023.10.043","volume":"213","author":"GB Justino","year":"2024","unstructured":"Justino GB, Justino LB, M\u00fcller ME, Rocha AV, Mazetto A, Cardoso R, et al. Early initiation of PCSK9 inhibitor therapy versus placebo in patients with acute coronary syndrome: a systematic review and meta-analysis. Am J Cardiol. 2024;213:110\u20138.","journal-title":"Am J Cardiol"},{"key":"1321_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1433010","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Luo Y, Liang H, Wei Z, Ye X, Zhong P, et al. Predictors of early neurological deterioration in patients with acute ischemic stroke. Front Neurol. 2024;15:1433010.","journal-title":"Front Neurol"},{"key":"1321_CR43","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2147\/TCRM.S515542","volume":"21","author":"B Hu","year":"2025","unstructured":"Hu B, Hua J. Impact of onset-to-needle time on the risk of early neurological deterioration in patients with acute ischemic stroke receiving intravenous thrombolysis. Ther Clin Risk Manag. 2025;21:917\u201327.","journal-title":"Ther Clin Risk Manag"},{"key":"1321_CR44","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.2147\/JIR.S317147","volume":"14","author":"QW Deng","year":"2021","unstructured":"Deng QW, Huang S, Li S, Zhai Q, Zhang Q, Wang ZJ, et al. Inflammatory factors as potential markers of early neurological deterioration in acute ischemic stroke patients receiving endovascular therapy - the AISRNA study. J Inflamm Res. 2021;14:4399\u2013407.","journal-title":"J Inflamm Res"},{"issue":"4","key":"1321_CR45","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10787-023-01209-w","volume":"31","author":"M Klement","year":"2023","unstructured":"Klement M, Drexel H, Saely CH. Impact of ezetimibe on markers of inflammation in patients treated with statins: a systematic review. Inflammopharmacology. 2023;31(4):1647\u201356.","journal-title":"Inflammopharmacology"},{"issue":"3","key":"1321_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023328","volume":"11","author":"E Punch","year":"2022","unstructured":"Punch E, Klein J, Diaba\u2010Nuhoho P, Morawietz H, Garelnabi M. Effects of PCSK9 targeting: alleviating oxidation, inflammation, and atherosclerosis. J Am Heart Assoc. 2022;11(3):e023328.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"1321_CR47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40263-024-01145-5","volume":"39","author":"W Tian","year":"2025","unstructured":"Tian W, Cao H, Li X, Gong X, Yu X, Li D, et al. Adjunctive PCSK9 inhibitor evolocumab in the prevention of early neurological deterioration in non-cardiogenic acute ischemic stroke: a multicenter, prospective, randomized, open-label, clinical trial. CNS Drugs. 2025;39(2):197\u2013208.","journal-title":"CNS Drugs"},{"issue":"12","key":"1321_CR48","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1007\/s00415-016-8283-0","volume":"263","author":"L Yang","year":"2016","unstructured":"Yang L, Zhao P, Zhao J, Wang J, Shi L, Wang X. Effects of ezetimibe and anticoagulant combined therapy on progressing stroke: a randomized, placebo-controlled study. J Neurol. 2016;263(12):2438\u201345.","journal-title":"J Neurol"},{"issue":"10","key":"1321_CR49","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40265-025-02222-9","volume":"85","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Huang W, Zhang Y, Ji Q. Tirofiban in acute ischemic stroke: mechanistic rationale, clinical advances, and emerging therapeutic strategies. Drugs. 2025;85(10):1269\u201387.","journal-title":"Drugs"},{"issue":"6","key":"1321_CR50","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jama.2022.12584","volume":"328","author":"Z Qiu","year":"2022","unstructured":"Qiu Z, Li F, Sang H, Luo W, Liu S, Liu W, et al. Effect of Intravenous Tirofiban vs Placebo Before Endovascular Thrombectomy on Functional Outcomes in Large Vessel Occlusion Stroke: The RESCUE BT Randomized Clinical Trial. JAMA. 2022;328(6):543\u201353.","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1007\/s40263-026-01332-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000}}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-026-01321-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-026-01321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:44:18Z","timestamp":1792010658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-026-01321-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s40263-026-01321-9","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication, the author name 'Heejung Mo' and affiliation number 6 were corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40263-026-01332-6","URL":"https:\/\/doi.org\/10.1007\/s40263-026-01332-6","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Conceptualization: H.G.W., T-J.S., M-Y.E., H-K.P.; Methodology: H.G.W., J.P., T-J.S., M-Y.E., H.M., H-K.P.; Formal analysis and investigation: H.G.W., J.P., T-J.S., M-Y.E., H.M., H-K.P.; Writing - original draft preparation: H.G.W., J.P., T-J.S., M-Y.E., H.M., H-K.P.; Writing - review and editing: H.G.W., J.P., T-J.S., M-Y.E., H.M., H-K.P. Funding acquisition: H-K.P.; Resources: H.G.W., T-J.S., M-Y.E., H-K.P.; Supervision: H.G.W., J.P., T-J.S., M-Y.E., H.M., H-K.P. All authors approved the final version of the manuscript.","order":1,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data set supporting the results of our study is available from the corresponding author upon reasonable request, who uses the full dataset and takes responsibility for its integrity and analysis.","order":3,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of Inha University Hospital (IRB number 2020-05-009).","order":4,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients signed informed consent regarding publishing their data and photographs.","order":6,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}